BCA
EGRX

Berman Capital Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Berman Capital Advisors’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		$1K Hold
35
– – ﹤0.01% 2008
2021
Q2 		$1K Buy
35
+3
+9% +$86 ﹤0.01% 1841
2021
Q1 		$1K Hold
32
– – ﹤0.01% 1720
2020
Q4 		$1K Hold
32
– – ﹤0.01% 1614
2020
Q3 		$1K Buy
+32
New +$1K ﹤0.01% 1544